thiazolyl blue has been researched along with bicalutamide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruchovsky, N; Sadar, MD; Ueda, T | 1 |
| Baumforth, KR; Bouchal, J; Kolár, Z; Murray, PG; Sváchová, M; von Angerer, E | 1 |
| Kong, Y; Qu, F; Yan, X; Yu, W; Yuan, X | 1 |
3 other study(ies) available for thiazolyl blue and bicalutamide
| Article | Year |
|---|---|
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Topics: Amino Acids; Anilides; Blotting, Northern; Colforsin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Immunoblotting; Interleukin-6; Janus Kinase 1; Luciferases; Male; MAP Kinase Signaling System; Models, Biological; Nitriles; Phosphorylation; Plasmids; Precipitin Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; STAT3 Transcription Factor; Tetrazolium Salts; Thiazoles; Tosyl Compounds; Trans-Activators; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 2002 |
Microarray analysis of bicalutamide action on telomerase activity, p53 pathway and viability of prostate carcinoma cell lines.
Topics: Androgen Antagonists; Androgens; Anilides; Blotting, Western; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; Genes, p53; Humans; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA; Telomerase; Tetrazolium Salts; Thiazoles; Tosyl Compounds | 2005 |
Effect of Bicalutamide on the proliferation and invasion of human triple negative breast cancer MDA-MB-231 cells.
Topics: Adult; Anilides; Cell Proliferation; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Nitriles; Tetrazolium Salts; Tosyl Compounds; Triple Negative Breast Neoplasms | 2020 |